Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data 1 from Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial
  1. Home
  2. Publications
  3. Supplementary Data 1 from Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial

Supplementary Data 1 from Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial

Authors:
  • SPSanteri A. Pakola
    Santeri A. Pakola
  • KPKatriina J. Peltola
    Katriina J. Peltola
  • JCJames H.A. Clubb
    James H.A. Clubb
  • EJElise Jirovec
    Elise Jirovec
  • LHLyna Haybout
    Lyna Haybout
  • TKTatiana V. Kudling
    Tatiana V. Kudling
  • TATuomo Alanko
    Tuomo Alanko
  • RKRiitta Korpisaari
    Riitta Korpisaari
  • SJSusanna Juteau
    Susanna Juteau
  • MJMarjut Jaakkola
    Marjut Jaakkola
  • JSJorma Sormunen
    Jorma Sormunen
  • JKJukka Kemppainen
    Jukka Kemppainen

Open Access
Publisher website
Google Scholar
  • 3 September 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.26926513.v1
Abstract
Supplementary Table S1-S5, Supplementary Figure S1-S6
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • DRUG MECHANISMS
  • CELLULAR RESPONSES TO ANTICANCER DRUGS
  • IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.